Le Lézard
Classified in: Health
Subject: SVY

Global Surgical and Nonwoven Disposable Market 2017-2021 - One Driver in the Market is Cost-effectiveness of Nonwoven Medical Textiles


DUBLIN, November 24, 2017 /PRNewswire/ --

The "Global Surgical and Nonwoven Disposable Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global surgical and nonwoven disposable market to grow at a CAGR of 7.79% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global surgical and nonwoven disposable market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in the market is cost-effectiveness of nonwoven medical textiles. Drapes and gowns provide protection from contaminations during surgeries. There are several parameters involved in selecting the appropriate drapes and gowns. These include surgeon comfort, patient spread, and limited transfer of infection. Nonwoven materials are used to make masks and head caps. Surgical nonwovens are absorbent pads; apparels for patients, surgeons, and staff; bed linen; gowns; facemasks; pillows and shoe covers; sponges; towels; and wraps. These products prevent the spread of infections.

One trend in the market is rise of single-use spinal products. Spinal surgeries involve lengthy recovery periods. This is due to the criticality involved in the process and the utmost care needed after surgery. Spinal fusion, laminectomy, and disk replacement are the common spinal procedures.

Further, the report states that one challenge in the market is increasing volume of disposable waste causing environmental damage. The increasing volume of medical waste is an environmental concern. Medical waste is incarcerated to prevent infections. However, medical waste causes pollution due to the use of non-biodegradable materials in producing disposable medical supplies. The increasing adoption of disposable medical supplies has increased the volume of medical waste. Developed countries such as the UK and the US generate a significant volume of medical waste. Developing countries such as China and India do have stringent regulations about the disposal of medical waste.

Key vendors

Other prominent vendors

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Segmentation By Application

Part 07: Market Segmentation By End-User

Part 08: Segmentation By Geography

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/4ctm2j/global_surgical

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...



News published on and distributed by: